Does Adding Transdermal Nitroglycerine to Other Therapies Used for Management of Left-sided Congestive Heart Failure in Dogs Speed the Resolution of Clinical Signs?
Article Links
Abstract
There is an erratum to this paper published in Veterinary Evidence Vol 3, Issue 1 (2018): http://dx.doi.org/10.18849/ve.v3i1.168
Clinical bottom line
There is very weak veterinary clinical and experimental evidence based upon a limited number of studies to indicate that adding transdermal nitroglycerine to other therapies used for management of left-sided congestive heart failure in dogs speeds the resolution of clinical signs.
